IGM Biosciences (IGMS) stock faces a downgrade to Underperform by Bank of America, citing cash concerns by 2027 and unclear strategic plans. Read more here.

Apple's stock has been hit hard since the Trump administration unveiled sweeping tariffs last week, but Bank of America ...

Alcoa double downgraded at Bank of America, driven by lower earnings estimates due to a weaker outlook for aluminum and ...